These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37420135)

  • 1. Molecular insights of anti-diabetic compounds and its hyaluronic acid conjugates against aldose reductase enzyme through molecular modeling and simulations study-a novel treatment option for inflammatory diabetes.
    Jayabal D; Jayanthi S; Thirumalaisamy R; Shimu MSS
    J Mol Model; 2023 Jul; 29(8):238. PubMed ID: 37420135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights of hyaluronic acid - ethambutol and hyaluronic acid - isoniazid drug conjugates act as promising novel drugs for the treatment of tuberculosis.
    Thirumalaisamy R; Aroulmoji V; Iqbal MN; Saride S; Bhuvaneswari M; Deepa M; Sivasankar C; Khan R
    J Biomol Struct Dyn; 2023 May; 41(8):3562-3573. PubMed ID: 35293842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative anti-Diabetic potential of phytocompounds from Dr. Duke's phytochemical and ethnobotanical database and standard antidiabetic drugs against diabetes hyperglycemic target proteins: an
    Jayabal D; Jayanthi S; Thirumalaisamy R; Karthika R; Iqbal MN
    J Biomol Struct Dyn; 2023; 41(24):15137-15149. PubMed ID: 37011006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico Designing of Novel Inhibitors for Triple Inhibition of Aldose Reductase, Aldose Reductase Like Protein 1, and Aldehyde Reductase.
    Devi A
    Curr Comput Aided Drug Des; 2020; 16(6):707-717. PubMed ID: 31749429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of Tephrosia purpurea in diabetic cataract through aldose reductase inhibitory activity.
    Bhadada SV; Vyas VK; Goyal RK
    Biomed Pharmacother; 2016 Oct; 83():221-228. PubMed ID: 27372406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology based high throughput screening for identification of multi targeted anti-diabetic compound from traditionally used plants.
    Gogoi B; Gogoi D; Gogoi N; Mahanta S; Buragohain AK
    J Biomol Struct Dyn; 2022 Oct; 40(17):8004-8017. PubMed ID: 33769188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Study of Asian Propolis Compounds as Potential Anti-Type 2 Diabetes Mellitus Agents by Using Inverse Virtual Screening with the DIA-DB Web Server, Tanimoto Similarity Analysis, and Molecular Dynamic Simulation.
    Syaifie PH; Harisna AH; Nasution MAF; Arda AG; Nugroho DW; Jauhar MM; Mardliyati E; Maulana NN; Rochman NT; Noviyanto A; Banegas-Luna AJ; Pérez-Sánchez H
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.
    Qi JH; Chen PY; Cai DY; Wang Y; Wei YL; He SP; Zhou W
    Front Endocrinol (Lausanne); 2022; 13():1096655. PubMed ID: 36699034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational investigation of phytochemicals from
    Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
    J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel quinazolinone-based 2,4-thiazolidinedione-3-acetic acid derivatives as potent aldose reductase inhibitors.
    Metwally K; Pratsinis H; Kletsas D; Quattrini L; Coviello V; Motta C; El-Rashedy AA; Soliman ME
    Future Med Chem; 2017 Dec; 9(18):2147-2166. PubMed ID: 29098865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular insight of phytocompounds from Indian spices and its hyaluronic acid conjugates to block SARS-CoV-2 viral entry.
    Rajamanickam K; Rathinavel T; Periyannan V; Ammashi S; Marimuthu S; Nasir Iqbal M
    J Biomol Struct Dyn; 2023; 41(15):7386-7405. PubMed ID: 36093954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
    Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
    J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the interactional details between aldose reductase (AKR1B1) and 3-Mercapto-5H-1,2,4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations.
    Zhan JY; Ma K; Zheng QC; Yang GH; Zhang HX
    J Biomol Struct Dyn; 2019 Apr; 37(7):1724-1735. PubMed ID: 29671687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Targeted Molecular Docking, Pharmacokinetics, and Drug-Likeness Evaluation of Okra-Derived Ligand Abscisic Acid Targeting Signaling Proteins Involved in the Development of Diabetes.
    Ashraf SA; Elkhalifa AEO; Mehmood K; Adnan M; Khan MA; Eltoum NE; Krishnan A; Baig MS
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641501
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular modeling, dynamics studies and density functional theory approaches to identify potential inhibitors of SIRT4 protein from Homo sapiens : a novel target for the treatment of type 2 diabetes.
    Choubey SK; Prabhu D; Nachiappan M; Biswal J; Jeyakanthan J
    J Biomol Struct Dyn; 2017 Nov; 35(15):3316-3329. PubMed ID: 27800715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationship Study Reveals Benzazepine Derivatives of Luteolin as New Aldose Reductase Inhibitors for Diabetic Cataract.
    Sebastian J
    Curr Drug Discov Technol; 2016; 13(3):152-163. PubMed ID: 27396410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of antidiabetic properties of shikonin by targeting aldose reductase enzyme: In silico and in vitro studies.
    Saeed M; Tasleem M; Shoaib A; Alabdallah NM; Alam MJ; El Asmar Z; Jamal QMS; Bardakci F; Ansari IA; Ansari MJ; Wang F; Badraoui R; Yadav DK
    Biomed Pharmacother; 2022 Jun; 150():112985. PubMed ID: 35658219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.